“I think everyone who wants it has already gotten it,” a health worker was told, holding a cooler of soon-to-expire COVID-19 vaccines doses. All went unused.    

In the US, reports of a rare blood clotting disorder in female recipients of the Johnson & Johnson COVID-19 vaccine have raised the possibility that the jab could be recommended just for men,

While the CDC and FDA review data today on reports that 6 women experienced very rare but serious blood clots in the brain after receiving the Johnson & Johnson jab, public health experts offered advice–and reassurance that the risk is low–-to the ~7million who already…

One possibility: US regulators could follow the lead of Europe, which limited the AstraZeneca vaccine to certain age groups; or it may add cautionary clauses,

The CDC and FDA recommended a temporary pause on the use of Johnson & Johnson’s COVID-19 vaccine in the US out of “an abundance of caution” over 6 cases of a rare but severe type of blood clot among recipients, 

Massive Blunder or “Blip”? 15 million doses of would-be Johnson & Johnson COVID-19 vaccines had to be discarded after a Baltimore plant run by Emergent BioSolutions—a company central to Johnson & Johnson’s US production plan—mixed ingredients with…

After initially rejecting Johnson & Johnson vaccines—saying they were “very good” but “not as good” as the Moderna and Pfizer’s—Detroit Mayor Mike Duggan walked back his statement, 

The Biden administration moved up the US vaccination schedule by 2 months yesterday, promising enough doses to vaccinate all US adults by May’s end,

Johnson & Johnson’s COVID-19 vaccine secured approvals for widespread use by the

More evidence is rolling in that COVID-19 variants can challenge the protective power of vaccines.